Weng, J. et al. 2026. Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterology Research. 19, 3 (Jan. 2026), 147–154. DOI:https://doi.org/10.14740/gr2136.